New Pharmacological Approaches to the Cholinergic System: An Overview on Muscarinic Receptor Ligands and Cholinesterase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|8|2|123-141

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.8, Iss.2, 2013-08, pp. : 123-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 85-100

Bentham Science Publishers

Access to resources Recommend Favorite

Risk of Pneumonia in New Users of Cholinesterase Inhibitors for Dementia

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 5, 2015-05 ,pp. : 869-876

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 8, 2015-08 ,pp. : 1512-1518

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of sigma (σ1) receptor‐selective ligands on muscarinic receptor antagonist‐induced cognitive deficits in mice

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2519-2531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cholinergic Receptor System as a Target for Treating Alcohol Abuse and Dependence

By  

Recent Patents on CNS Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 145-150

Bentham Science Publishers

Access to resources Recommend Favorite